{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:35:14Z","timestamp":1788820514145,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61905280"],"award-info":[{"award-number":["61905280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104303"],"award-info":[{"award-number":["82104303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.thromres.2023.10.021","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T00:30:45Z","timestamp":1700872245000},"page":"88-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"233","author":[{"given":"Qiang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Zi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ying","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.thromres.2023.10.021_bb0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/hrt.2002.008748","article-title":"Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK","volume":"90","author":"Stewart","year":"2004","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.thromres.2023.10.021_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.thromres.2023.10.021_bb0015","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.thromres.2023.10.021_bb0020","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.4244\/EIJ-D-19-00128","article-title":"Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study","volume":"15","author":"Cresti","year":"2019","journal-title":"Eurointervention"},{"issue":"12","key":"10.1016\/j.thromres.2023.10.021_bb0025","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jacep.2019.09.003","article-title":"Prevalence and management of atrial thrombi in patients with atrial fibrillation before pulmonary vein isolation","volume":"5","author":"G\u00f6ldi","year":"2019","journal-title":"JACC-Clin Electrophy"},{"issue":"2","key":"10.1016\/j.thromres.2023.10.021_bb0030","first-page":"199","article-title":"Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives","volume":"7","author":"Kong","year":"2015","journal-title":"J. Thorac. Dis."},{"issue":"10","key":"10.1016\/j.thromres.2023.10.021_bb0035","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER cardiac plug","volume":"11","author":"Tzikas","year":"2016","journal-title":"Eurointervention"},{"issue":"9689","key":"10.1016\/j.thromres.2023.10.021_bb0040","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.thromres.2023.10.021_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.thromres.2023.10.021_bb0050","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.thromres.2023.10.021_bb0055","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.thromres.2023.10.021_bb0060","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.thromres.2023.10.021_bb0065","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2023.10.021_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.thromres.2023.10.021_bb0075","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.thromres.2023.10.021_bb0080","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.thromres.2023.10.021_bb0085","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.thromres.2023.10.021_bb0090","first-page":"937","article-title":"Chinese Society of Cardiology (CSC) expert consensus statement on left atrial appendage closure in the prevention of stroke in patients with atrial fibrillation. Article in Chinese","volume":"47","author":"Chinese Society of Cardiology of Chinese Medical Association","year":"2019","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.thromres.2023.10.021_bb0095","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.thromres.2023.10.021_bb0100","unstructured":"Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of 26 on randomized studies in meta-analyses [Online]. Ottawa Hospital Research Institute Research Programs. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"5","key":"10.1016\/j.thromres.2023.10.021_bb0105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.14594","article-title":"Periprocedural outcomes associated with use of a left atrial appendage occlusion device in China","volume":"5","author":"Su","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.thromres.2023.10.021_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10840-021-00958-4","article-title":"Outcomes in patients implanted with a Watchman device in relation to choice of anticoagulation and indication for implant","volume":"64","author":"Ajmal","year":"2022","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"10.1016\/j.thromres.2023.10.021_bb0115","article-title":"Safety and efficacy of direct Oral anticoagulants vs warfarin following WATCHMAN in high-risk patients","volume":"1","author":"Tan","year":"2022","journal-title":"J Soc Cardiovasc Angiog Interv"},{"issue":"18","key":"10.1016\/j.thromres.2023.10.021_bb0120","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation","volume":"79","author":"Freeman","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.thromres.2023.10.021_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/00368504221113194","article-title":"Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion","volume":"105","author":"Ge","year":"2022","journal-title":"Sci. Prog."},{"issue":"8","key":"10.1016\/j.thromres.2023.10.021_bb0130","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jfma.2021.10.015","article-title":"Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device","volume":"121","author":"Fu","year":"2022","journal-title":"J. Formos. Med. Assoc."},{"issue":"3","key":"10.1016\/j.thromres.2023.10.021_bb0135","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s11239-021-02408-4","article-title":"Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure","volume":"52","author":"Chen","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2023.10.021_bb0140","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2147\/DDDT.S293812","article-title":"The use of novel non-vitamin K antagonist oral anticoagulants following closure of the left atrial appendage: preliminary results of clinical follow-up","volume":"15","author":"Zhu","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.021_bb0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10840-020-00790-2","article-title":"Watchman outcomes comparing post-implantation anticoagulation with warfarin versus direct oral anticoagulants","volume":"61","author":"Fry","year":"2021","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"10.1016\/j.thromres.2023.10.021_bb0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/24748706.2021.1890286","article-title":"Use of direct Oral anticoagulation therapy following implantation of the Watchman left atrial appendage occlusion device","volume":"5","author":"Tjoe","year":"2021","journal-title":"Structural Heart."},{"issue":"10","key":"10.1016\/j.thromres.2023.10.021_bb0155","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/pace.13796","article-title":"A comparison of postprocedural anticoagulation in high-risk patients undergoing WATCHMAN device implantation","volume":"42","author":"Cohen","year":"2019","journal-title":"Pace"},{"issue":"7","key":"10.1016\/j.thromres.2023.10.021_bb0160","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4244\/EIJ-D-17-00042","article-title":"Safety and efficacy of early anticoagulation drug regimens after WATCHMAN left atrial appendage closure: three-month data from the EWOLUTION prospective, multicentre, monitored international WATCHMAN LAA closure registry","volume":"13","author":"Bergmann","year":"2017","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.thromres.2023.10.021_bb0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hrthm.2016.10.020","article-title":"Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device","volume":"14","author":"Enomoto","year":"2017","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.thromres.2023.10.021_bb0170","article-title":"Device-related Thrombus after left atrial appendage closure: data on Thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-registry","volume":"14","author":"Sedaghat","year":"2021","journal-title":"Circ-Cardiovasc Inter."},{"issue":"11","key":"10.1016\/j.thromres.2023.10.021_bb0175","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jcin.2018.11.001","article-title":"Antithrombotic therapy and device-related thrombosis following endovascular left atrial appendage closure","volume":"12","author":"Saw","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"issue":"13","key":"10.1016\/j.thromres.2023.10.021_bb0180","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.thromres.2023.10.021_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0300060520966478","article-title":"Meta-analysis of postoperative antithrombotic therapy after left atrial appendage occlusion","volume":"48","author":"Li","year":"2020","journal-title":"J. Int. Med. Res."},{"issue":"11","key":"10.1016\/j.thromres.2023.10.021_bb0190","article-title":"Direct Oral anticoagulant versus warfarin after left atrial appendage closure with WATCHMAN: updated systematic review and meta-analysis","volume":"47","author":"Tan","year":"2022","journal-title":"Curr Prob Cardiology"},{"key":"10.1016\/j.thromres.2023.10.021_bb0195","doi-asserted-by":"crossref","first-page":"1023941","DOI":"10.3389\/fcvm.2022.1023941","article-title":"Comparison of outcomes between novel oral anticoagulants and warfarin monotherapy in patients with left atrial appendage closure: a systematic review and meta-analysis","volume":"9","author":"Sun","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.thromres.2023.10.021_bb0200","article-title":"Left atrial appendage closure with WATCHMAN in Asian patients: 2\u00a0year outcomes from the WASP registry","volume":"23","author":"Phillips","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.thromres.2023.10.021_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2023-322492","article-title":"Anticoagulant in atrial fibrillation patients with prior intracranial haemorrhage: a meta-analysis","author":"Cai","year":"2023","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.thromres.2023.10.021_bb0210","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00228-022-03300-7","article-title":"Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data","volume":"78","author":"Hu","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.021_bb0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.amjcard.2017.03.253","article-title":"Changes in coagulation and platelet activation markers following Transcatheter left atrial appendage closure","volume":"120","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.thromres.2023.10.021_bb0220","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jcin.2019.04.004","article-title":"Propensity-matched comparison of Oral anticoagulation versus antiplatelet therapy after left atrial appendage closure with WATCHMAN","volume":"12","author":"S\u00f8ndergaard","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.thromres.2023.10.021_bb0225","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2021.02.054","article-title":"Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy","volume":"333","author":"Faroux","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.thromres.2023.10.021_bb0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11239-021-02602-4","article-title":"Antiplatelet therapy indication in patients also prescribed direct oral anticoagulants","volume":"55","author":"Amirtabar","year":"2023","journal-title":"J Thromb Thrombolys"},{"issue":"7","key":"10.1016\/j.thromres.2023.10.021_bb0235","article-title":"Reduced rivaroxaban dose versus dual antiplatelet therapy after left atrial appendage closure: ADRIFT a randomized pilot study","volume":"13","author":"Duthoit","year":"2020","journal-title":"Circ-Cardiovasc Inte"},{"key":"10.1016\/j.thromres.2023.10.021_bb0240","article-title":"Clinical efficacy and safety comparison of rivaroxaban and dabigatran for Nonvalvular atrial fibrillation patients undergoing percutaneous left atrial appendage closure operation","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"21","key":"10.1016\/j.thromres.2023.10.021_bb0245","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"Jacc-Cardiovasc Inte"},{"issue":"12","key":"10.1016\/j.thromres.2023.10.021_bb0250","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jacep.2021.04.012","article-title":"Incidence of device-related thrombosis in Watchman patients undergoing a genotype-guided antithrombotic strategy","volume":"7","author":"Della Rocca","year":"2021","journal-title":"Jacc-Clin Electrophy"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:52:23Z","timestamp":1758736343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823003390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":50,"alternative-id":["S0049384823003390"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.021","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of short-term anticoagulant regimens after left atrial appendage occlusion: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}